Assets Veränderung Datum
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Almirall EUR 2.4B 75.28M 2024-12
Amarin USD 750.62M 49.24M 2024-09
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Bayer EUR 109.18B 1.67B 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Demant DKK 32.45B 60M 2024-12
Exelixis USD 2.84B 110.44M 2025-04
Fresenius Medical Care EUR 32.74B 832M 2025-03
Galapagos EUR 4.02B 113.77M 2025-03
Genmab DKK 6.59B 39.22B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
GN Store Nord DKK 29.94B 8.26B 2025-03
GRIFOLS EUR 20.98B 426.68M 2025-03
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Insmed USD 1.8B 222.5M 2025-03
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
UCB EUR 17.35B 1.72B 2024-12



Genmab Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.